Zacks Investment Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Zacks Investment Management's VCYT Position: Q2 2026 in Review
Zacks Investment Management increased its Veracyte (VCYT) stake by 17% in Q2 2026, buying an estimated $375K and bringing the position to 62,229 shares worth $3.65M. The position accounts for 0.03% of the portfolio, ranked #293.
Zacks Investment Management first reported a position in VCYT in Q3 2024 and has held it in 8 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Zacks Investment Management held 62,229 shares of Veracyte worth $3.65M as of Q2 2026.
- Zacks Investment Management bought 8,935 Veracyte shares in Q2 2026, an estimated $375K.
- Veracyte made up 0.03% of Zacks Investment Management's portfolio in Q2 2026, its #293 holding.
- Zacks Investment Management first reported a position in Veracyte in Q3 2024 and has held it in 8 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.